Alma Muñoz

1.1k total citations
18 papers, 786 citations indexed

About

Alma Muñoz is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, Alma Muñoz has authored 18 papers receiving a total of 786 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 11 papers in Microbiology and 3 papers in Infectious Diseases. Recurrent topics in Alma Muñoz's work include Pneumonia and Respiratory Infections (13 papers), Bacterial Infections and Vaccines (11 papers) and Respiratory viral infections research (9 papers). Alma Muñoz is often cited by papers focused on Pneumonia and Respiratory Infections (13 papers), Bacterial Infections and Vaccines (11 papers) and Respiratory viral infections research (9 papers). Alma Muñoz collaborates with scholars based in United States, Chile and Italy. Alma Muñoz's co-authors include Rosanna Lagos, María Teresa Valenzuela, Rodrigo Vergara, Daniela Toneatto, Marı́a Elena Santolaya, Valeria Prado, Peter Dull, Myron M. Levine, Miguel L. O’Ryan and Ralf Clemens and has published in prestigious journals such as The Lancet, American Journal of Respiratory and Critical Care Medicine and The Journal of Infectious Diseases.

In The Last Decade

Alma Muñoz

18 papers receiving 742 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alma Muñoz United States 12 656 430 113 77 65 18 786
J. Rüggeberg United Kingdom 9 493 0.8× 191 0.4× 197 1.7× 40 0.5× 84 1.3× 13 734
Charles Omosigho Gambia 7 458 0.7× 263 0.6× 55 0.5× 40 0.5× 55 0.8× 8 550
Antonio Arbo Paraguay 11 279 0.4× 235 0.5× 140 1.2× 193 2.5× 26 0.4× 57 506
Pamela S. Palmer United States 6 331 0.5× 253 0.6× 46 0.4× 35 0.5× 32 0.5× 7 415
Josefina Fernández United States 10 330 0.5× 205 0.5× 74 0.7× 124 1.6× 36 0.6× 17 551
Joanne Wolter Belgium 15 370 0.6× 312 0.7× 144 1.3× 11 0.1× 77 1.2× 16 543
M Rush United States 8 339 0.5× 205 0.5× 151 1.3× 54 0.7× 29 0.4× 12 543
Helena Mäkelä Finland 8 367 0.6× 183 0.4× 34 0.3× 37 0.5× 41 0.6× 10 504
Michael Buettcher Switzerland 12 207 0.3× 46 0.1× 133 1.2× 51 0.7× 47 0.7× 37 560
Hiroto Akaike Japan 16 760 1.2× 488 1.1× 50 0.4× 59 0.8× 74 1.1× 35 863

Countries citing papers authored by Alma Muñoz

Since Specialization
Citations

This map shows the geographic impact of Alma Muñoz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alma Muñoz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alma Muñoz more than expected).

Fields of papers citing papers by Alma Muñoz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alma Muñoz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alma Muñoz. The network helps show where Alma Muñoz may publish in the future.

Co-authorship network of co-authors of Alma Muñoz

This figure shows the co-authorship network connecting the top 25 collaborators of Alma Muñoz. A scholar is included among the top collaborators of Alma Muñoz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alma Muñoz. Alma Muñoz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kochhar, Sonali, David N. Assis, Cara L. Mack, et al.. (2024). Autoimmune hepatitis: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunisation safety data. Vaccine. 42(7). 1812–1825. 2 indexed citations
2.
Fíca, Alberto, et al.. (2016). Opinión del Comité Consultivo de Inmunizaciones Sociedad Chilena de Infectología: Vacuna neumocóccica conjugada en niños y la emergencia de serotipo 19A. Revista chilena de infectología. 33(3). 304–306. 20 indexed citations
3.
Santolaya, Marı́a Elena, Miguel O’Ryan, María Teresa Valenzuela, et al.. (2013). Persistence of antibodies in adolescents 18−24 months after immunization with one, two, or three doses of 4CMenB meningococcal serogroup B vaccine. Human Vaccines & Immunotherapeutics. 9(11). 2304–2310. 66 indexed citations
4.
5.
Santolaya, Marı́a Elena, Miguel L. O’Ryan, María Teresa Valenzuela, et al.. (2012). Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study. The Lancet. 379(9816). 617–624. 199 indexed citations
6.
Simon, Jakub K., Karina Ramírez, James D. Campbell, et al.. (2011). Mucosal IgA Responses in Healthy Adult Volunteers following Intranasal Spray Delivery of a Live Attenuated Measles Vaccine. Clinical and Vaccine Immunology. 18(3). 355–361. 19 indexed citations
7.
Lagos, Rosanna, Alma Muñoz, Myron M. Levine, et al.. (2011). Safety and immunogenicity of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Chilean children. Human Vaccines. 7(5). 511–522. 28 indexed citations
8.
Lagos, Rosanna, et al.. (2009). Costos médicos directos de enfermedades neumocócicas invasoras y neumonías con diagnóstico radiológico en niños chilenos. Revista Panamericana de Salud Pública. 26(2). 101–111. 5 indexed citations
9.
Lagos, Rosanna, John P. DeVincenzo, Alma Muñoz, et al.. (2009). SAFETY AND ANTIVIRAL ACTIVITY OF MOTAVIZUMAB, A RESPIRATORY SYNCYTIAL VIRUS (RSV)–SPECIFIC HUMANIZED MONOCLONAL ANTIBODY, WHEN ADMINISTERED TO RSV-INFECTED CHILDREN. The Pediatric Infectious Disease Journal. 28(9). 835–837. 44 indexed citations
10.
Lagos, Rosanna, Alma Muñoz, Myron M. Levine, et al.. (2009). Immunology of combining CRM197 conjugates for Streptococcus pneumoniae, Neisseria meningitis and Haemophilus influenzae in Chilean infants. Vaccine. 27(17). 2299–2305. 10 indexed citations
11.
Lagos, Rosanna, Alma Muñoz, Oriana San Martin, et al.. (2008). Age‐ and Serotype‐Specific Pediatric Invasive Pneumococcal Disease: Insights from Systematic Surveillance in Santiago, Chile, 1994–2007. The Journal of Infectious Diseases. 198(12). 1809–1817. 54 indexed citations
12.
Simon, Jakub K., Marcela F. Pasetti, Jean‐François Viret, et al.. (2007). A Clinical Study to Assess the Safety and Immunogenicity of Attenuated Measles Vaccine Administered Intranasally to Healthy Adults. Human Vaccines. 3(2). 54–58. 11 indexed citations
13.
14.
Mallet, E., Bernd H. Belohradsky, Rosanna Lagos, et al.. (2003). A liquid hexavalent combined vaccine against diphtheria, tetanus, pertussis, poliomyelitis, Haemophilus influenzae type B and hepatitis B: review of immunogenicity and safety. Vaccine. 22(11-12). 1343–1357. 28 indexed citations
15.
Lagos, Rosanna, Alma Muñoz, Rafaele Dumas, et al.. (2003). Immunological priming of one dose of inactivated hepatitis A vaccine given during the first year of life in presence of maternal antibodies. Vaccine. 21(25-26). 3730–3733. 18 indexed citations
16.
Lagos, Rosanna, Alma Muñoz, María Teresa Valenzuela, Ingrid Heitmann, & Myron M. Levine. (2002). Population-based surveillance for hospitalized and ambulatory pediatric invasive pneumococcal disease in Santiago, Chile. The Pediatric Infectious Disease Journal. 21(12). 1115–1123. 60 indexed citations
17.
Levine, Orin S., Rosanna Lagos, Alma Muñoz, et al.. (1999). Defining the burden of pneumonia in children preventable by vaccination against Haemophilus influenzae type b. The Pediatric Infectious Disease Journal. 18(12). 1060–1064. 98 indexed citations
18.
Caiaffa, Waleska Teixeira, David Vlahov, Neil M.H. Graham, et al.. (1994). Drug Smoking, Pneumocystis Carinii Pneumonia, and Immunosuppression Increase Risk of Bacterial Pneumonia in Human Immunodeficiency Virus-Seropositive Injection Drug Users. American Journal of Respiratory and Critical Care Medicine. 150(6). 1493–1498. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Rüggeberg Breakdown of academic impact, for papers by Charles Omosigho Breakdown of academic impact, for papers by Antonio Arbo Breakdown of academic impact, for papers by Pamela S. Palmer Breakdown of academic impact, for papers by Josefina Fernández Breakdown of academic impact, for papers by Joanne Wolter Breakdown of academic impact, for papers by M Rush Breakdown of academic impact, for papers by Helena Mäkelä Breakdown of academic impact, for papers by Michael Buettcher Breakdown of academic impact, for papers by Hiroto Akaike
Rankless by CCL
2026